Brian Litten joined the Company in 2014 as Chief Strategic Growth Officer, General Counsel, and Chief Compliance Officer. After the Company’s IPO in 2016, Brian now focuses on the sustainable, strategic growth of the Company. In 2018, the charter of TRHC’s Office of Strategy Development was recast as the Office of Strategic Growth, emphasizing the evolving focus of the Office in developing and testing new models to foster the continued growth of TRHC. These models include the evaluation of payer, health system, international, and strategic channel partner growth opportunities.
Before joining the Company, Brian led the successful development and startup of two healthcare technology companies, including serving as CEO of PathForward Oncology in Bluffton, South Carolina. Brian has held management positions with regional health insurance companies, including Horizon Blue Cross Blue Shield of
New Jersey and AmeriHealth. Brian also served as Chief Legislative Counsel to New Jersey Governor Christine Todd Whitman.
Brian’s expertise in healthcare strategy, growth and policy has resulted in his past election as Chair of the New Jersey Association of Health Plans and as Senior Fellow at the Jefferson School of Population Health. Brian has also been appointed by several governors to serve on healthcare access and reform commissions
where he actively participated and co-authored final reports. Additionally, Brian was a member of the Board and the Executive Committee of the Coriell Institute for Medical Research (an international leader dedicated to the study of the human genome). Brian now serves on the Board of the Public Affairs Council in
Brian earned a Juris Doctor degree from Rutgers University School of Law and a Bachelor of Arts in Economics from Vassar College. He is admitted to the bars of New Jersey, Pennsylvania and the District of Columbia.